Eplerenone
- TRADE NAME: Inspra (Pfizer)
- INDICATIONS: Hypertension
- CLASS: Aldosterone antagonist, Diuretic
- HALF-LIFE: 4–6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE Inhibitors, Angiotensin II receptor antagonist, Aprepitant, Benazepril, Captopril, Conivaptan, Delavirdine, Enalapril, Erythromycin, Fluconazole, Grapefruit juice, Indinavir, Irbesartan, Itraconazole, Ketoconazole, Lapatinib, Lisinopril, Meloxicam, Nelfinavir, Olmesartan, Quinapril, Ramipril, Saquinavir, St John's Wort, Telithromycin, Trimethoprim, Verapamil
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
RESPIRATORY
ENDOCRINE/METABOLIC
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric